Prospective Comparison of Outcomes with Azacitidine and Decitabine in Patients with AML Ineligible for Intensive Chemotherapy.
Amer M Zeidan,Pierre Fenaux,Marco Gobbi,Jiří Mayer,Gail J Roboz,Jürgen Krauter,Tadeusz Robak,Hagop M Kantarjian,Jan Novák,Wieslaw W Jedrzejczak,Xavier Thomas,Mario Ojeda-Uribe,Yasushi Miyazaki,Yoo Hong Min,Su-Peng Yeh,Joseph M Brandwein,Liana Gercheva,Judit Demeter,Elizabeth A Griffiths,Karen W L Yee,Jean-Pierre J Issa,Jan Philipp Bewersdorf,Harold Keer,Yong Hao,Mohammad Azab,Hartmut Döhner Blood（2022）
AI 理解论文
溯源树
样例
